CA2983460A1 - Derivatives of korormicin useful as antibiotics - Google Patents
Derivatives of korormicin useful as antibioticsInfo
- Publication number
- CA2983460A1 CA2983460A1 CA2983460A CA2983460A CA2983460A1 CA 2983460 A1 CA2983460 A1 CA 2983460A1 CA 2983460 A CA2983460 A CA 2983460A CA 2983460 A CA2983460 A CA 2983460A CA 2983460 A1 CA2983460 A1 CA 2983460A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- vibrio
- bacteria
- group
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/66—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Furan Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562151902P | 2015-04-23 | 2015-04-23 | |
| US62/151,902 | 2015-04-23 | ||
| PCT/CA2016/050470 WO2016168938A1 (en) | 2015-04-23 | 2016-04-22 | Derivatives of korormicin useful as antibiotics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2983460A1 true CA2983460A1 (en) | 2016-10-27 |
Family
ID=57142747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2983460A Pending CA2983460A1 (en) | 2015-04-23 | 2016-04-22 | Derivatives of korormicin useful as antibiotics |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US10166213B2 (https=) |
| EP (1) | EP3285762A4 (https=) |
| JP (3) | JP6842089B2 (https=) |
| CN (2) | CN116574132A (https=) |
| AU (4) | AU2016253429B2 (https=) |
| CA (1) | CA2983460A1 (https=) |
| IL (2) | IL255182B2 (https=) |
| WO (1) | WO2016168938A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116574132A (zh) * | 2015-04-23 | 2023-08-11 | 维奥提卡生命科学股份有限公司 | 用作抗生素的Korormicin衍生物 |
| CN116617231B (zh) * | 2023-06-12 | 2024-11-15 | 沈阳药科大学 | 2-氨基萘嵌间二氮杂苯氢溴化物增强对革兰氏阴性菌杀菌作用的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2315489A (en) * | 1996-07-17 | 1998-02-04 | Merck & Co Inc | Antifungal agent |
| JP3905604B2 (ja) | 1997-03-04 | 2007-04-18 | 株式会社海洋バイオテクノロジー研究所 | 新規化学物質コロールミシン |
| JP2000281670A (ja) | 1999-03-26 | 2000-10-10 | Marine Biotechnol Inst Co Ltd | 新規コロールミシン合成中間体及び製造法 |
| JP2000336088A (ja) * | 1999-05-27 | 2000-12-05 | Marine Biotechnol Inst Co Ltd | 新規化学物質Ｆ４２０ｍ類縁体 |
| JP2001010908A (ja) * | 1999-06-28 | 2001-01-16 | Marine Biotechnol Inst Co Ltd | 防汚剤 |
| JP2003061645A (ja) | 2001-08-23 | 2003-03-04 | Marine Biotechnol Inst Co Ltd | 海洋細菌の選択培地 |
| EP2136800A4 (en) * | 2007-03-19 | 2011-10-05 | Wisconsin Alumni Res Found | MODULATION OF BACTERIAL QUORUM DETECTION WITH SYNTHETIC LIGANDS |
| EP2448930B1 (en) * | 2009-07-03 | 2017-02-15 | The National Institute for Biotechnology in the Negev Ltd. | N-((S)-2-Oxo-tetrahydro-furan-3-yl)-amide derivatives as inhibitors of the bacterial quorum sensing for treating plant or animal diseases and for preventing the formation of biofilms on medical devices |
| CN116574132A (zh) * | 2015-04-23 | 2023-08-11 | 维奥提卡生命科学股份有限公司 | 用作抗生素的Korormicin衍生物 |
-
2016
- 2016-04-22 CN CN202310483500.4A patent/CN116574132A/zh active Pending
- 2016-04-22 AU AU2016253429A patent/AU2016253429B2/en not_active Ceased
- 2016-04-22 CA CA2983460A patent/CA2983460A1/en active Pending
- 2016-04-22 WO PCT/CA2016/050470 patent/WO2016168938A1/en not_active Ceased
- 2016-04-22 IL IL255182A patent/IL255182B2/en unknown
- 2016-04-22 US US15/500,006 patent/US10166213B2/en active Active
- 2016-04-22 EP EP16782435.8A patent/EP3285762A4/en not_active Ceased
- 2016-04-22 JP JP2017555587A patent/JP6842089B2/ja active Active
- 2016-04-22 CN CN201680033925.3A patent/CN107708689A/zh active Pending
- 2016-04-22 IL IL310102A patent/IL310102A/en unknown
-
2018
- 2018-11-15 US US16/192,117 patent/US10744111B2/en active Active
-
2019
- 2019-04-02 AU AU2019202254A patent/AU2019202254B2/en not_active Ceased
-
2020
- 2020-07-15 US US16/930,178 patent/US11324716B2/en active Active
- 2020-11-11 AU AU2020267205A patent/AU2020267205B2/en not_active Ceased
-
2021
- 2021-02-03 JP JP2021015712A patent/JP7121225B2/ja active Active
-
2022
- 2022-03-02 JP JP2022032136A patent/JP2022122857A/ja active Pending
- 2022-04-27 US US17/660,886 patent/US12029716B2/en active Active
- 2022-07-08 AU AU2022204906A patent/AU2022204906B2/en not_active Ceased
-
2024
- 2024-07-08 US US18/766,386 patent/US20240358670A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019202254A1 (en) | 2019-05-02 |
| JP7121225B2 (ja) | 2022-08-18 |
| US20240358670A1 (en) | 2024-10-31 |
| JP2022122857A (ja) | 2022-08-23 |
| JP2018513194A (ja) | 2018-05-24 |
| AU2022204906A1 (en) | 2022-07-28 |
| AU2020267205B2 (en) | 2022-04-14 |
| EP3285762A1 (en) | 2018-02-28 |
| IL310102A (en) | 2024-03-01 |
| IL255182B1 (en) | 2024-02-01 |
| CN107708689A (zh) | 2018-02-16 |
| AU2020267205A1 (en) | 2020-12-10 |
| JP2021073278A (ja) | 2021-05-13 |
| US20180064680A1 (en) | 2018-03-08 |
| AU2016253429B2 (en) | 2019-01-03 |
| AU2022204906B2 (en) | 2024-03-28 |
| EP3285762A4 (en) | 2019-02-06 |
| AU2016253429A1 (en) | 2017-12-07 |
| US10744111B2 (en) | 2020-08-18 |
| US12029716B2 (en) | 2024-07-09 |
| IL255182A0 (en) | 2017-12-31 |
| US10166213B2 (en) | 2019-01-01 |
| US20220257555A1 (en) | 2022-08-18 |
| JP6842089B2 (ja) | 2021-03-17 |
| IL255182B2 (en) | 2024-06-01 |
| US20200345682A1 (en) | 2020-11-05 |
| AU2019202254B2 (en) | 2020-08-13 |
| US20190083450A1 (en) | 2019-03-21 |
| US11324716B2 (en) | 2022-05-10 |
| CN116574132A (zh) | 2023-08-11 |
| WO2016168938A1 (en) | 2016-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240358670A1 (en) | Derivatives of korormicin useful as antibiotics | |
| Dibrov et al. | Na+-NQR (Na+-translocating NADH: ubiquinone oxidoreductase) as a novel target for antibiotics | |
| US9913862B2 (en) | Methods of treating gram-negative microbial infections | |
| Wu et al. | Bacillomycin D effectively controls growth of Malassezia globosa by disrupting the cell membrane | |
| US8748661B2 (en) | Polyamino polyketide antibiotics and uses thereof | |
| Ohsuka et al. | Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways | |
| CA2413284A1 (fr) | Utilisation d'acides en c4-c10 pour la prevention des infections a bacteries a gram negatif | |
| JP2007521239A (ja) | 抗菌組成物及び使用方法 | |
| JP6590924B2 (ja) | 微生物感染を治療するための相乗的組成物 | |
| Dibrov | Searching for New Antimicrobial Targets: Na+ Cycle in Energetics of Bacterial Pathogens | |
| WO2024011227A1 (en) | Compounds and methods for inhibition of the evolution of antibiotic resistance | |
| Zhu et al. | The Novel Antimicrobial Activities of Carrimycin Against Multidrug Resistant Acinetobacter baumannii and Pseudomonas aeruginosa Systemic Infection | |
| CN119837893A (zh) | 5-氟-2′-脱氧胞苷在制备抗菌药物中的用途 | |
| Osborne | Antimicrobials and antimicrobial resistance: two studies investigating different ways to tackle the issue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210412 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20240823 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION Effective date: 20241223 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - SMALL Year of fee payment: 9 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250811 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250812 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251201 |